Kee Song Bio-Technology Holdings (ROCO:1258) Total Current Assets : NT$786 Mil (As of Mar. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Kee Song Bio-Technology Holdings's total current assets for the quarter that ended in Mar. 2023 was NT$786 Mil.

Kee Song Bio-Technology Holdings Total Current Assets Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings Total Current Assets Chart

Kee Song Bio-Technology Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Current Assets

Get a 7-Day Free Trial

853.64

779.24

890.71

689.55

840.62

Kee Song Bio-Technology Holdings Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Current Assets	Get a 7-Day Free Trial															664.94	694.91	622.85	840.62	786.33

Kee Song Bio-Technology Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Kee Song Bio-Technology Holdings's Total Current Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	342.8	+	207.212	+	257.821	+	32.784
	=	841

Kee Song Bio-Technology Holdings's Total Current Assets for the quarter that ended in Mar. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	344.276	+	172.356	+	234.097	+	35.599
	=	786

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Kee Song Bio-Technology Holdings (ROCO:1258) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Kee Song Bio-Technology Holdings's Liquidation Value for the quarter that ended in Mar. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	344.276	-	1509.079	+	0.75 * 143.753	+	0.5 * 234.097
=	-940

Kee Song Bio-Technology Holdings Total Current Assets Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104

Website

https://www.keesongbiotech.com

Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines